Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-011638
Filing Date
2022-08-02
Accepted
2022-08-02 16:07:44
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20220630x10q.htm   iXBRL 10-Q 2405223
2 EX-10.1 rigl-20220630xex10d1.htm EX-10.1 176910
3 EX-31.1 rigl-20220630xex31d1.htm EX-31.1 15895
4 EX-31.2 rigl-20220630xex31d2.htm EX-31.2 16781
5 EX-32.1 rigl-20220630xex32d1.htm EX-32.1 9072
6 GRAPHIC rigl-20220630x10q004.jpg GRAPHIC 123377
  Complete submission text file 0001558370-22-011638.txt   9064195

Data Files

Seq Description Document Type Size
7 EX-101.SCH rigl-20220630.xsd EX-101.SCH 52087
8 EX-101.CAL rigl-20220630_cal.xml EX-101.CAL 51484
9 EX-101.DEF rigl-20220630_def.xml EX-101.DEF 215901
10 EX-101.LAB rigl-20220630_lab.xml EX-101.LAB 465224
11 EX-101.PRE rigl-20220630_pre.xml EX-101.PRE 342249
64 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20220630x10q_htm.xml XML 1594428
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 221128716
SIC: 2834 Pharmaceutical Preparations